Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10Â years after first-ever ischemic stroke

All-cause mortality was independently associated with AF and was the greatest in stroke patients with permanent AF. Patients with recurrent AF receiving OAC have the most favorable outcome, similar to those without AF and significantly better than OAC-treated patients with permanent AF.